Lawmakers Reintroduce Industry-Physician Financial Disclosure Bill

Drug Industry Daily
A A
A bill designed to shine light on industry-physician financial relationships by requiring drugmakers to publicly report payments to physicians of more than $100 annually has been reintroduced in the 111th Congress.

To View This Article:

Login

Subscribe To Drug Industry Daily